Abstract
Peritoneum patch repair in oncologic major resections – An autolog alternative
Highlights
At diagnosis only 10-20% of pancreatic cancer patients present with primarily resectable disease; 20% have locally advanced unresectable or borderline resectable tumors and 60% have metastatic disease [1].Some of resectable are borderline resectable at surgery [2]
The evaluation of tumor extension to major vessels involved in the tumor mass, such as the inferior vena cava, superior mesenteric vein or portal vein, may not be a criterion of non resectability and lead to excision of the tumor mass with vascular resection [4]
This reconstruction may imply the need for prosthetic material if the length of autologous vessels is not sufficient, which is not the most desirable option
Summary
At diagnosis only 10-20% of pancreatic cancer patients present with primarily resectable disease; 20% have locally advanced unresectable or borderline resectable tumors and 60% have metastatic disease [1]. The evaluation of tumor extension to major vessels involved in the tumor mass, such as the inferior vena cava, superior mesenteric vein or portal vein, may not be a criterion of non resectability and lead to excision of the tumor mass with vascular resection [4]. This reconstruction may imply the need for prosthetic material if the length of autologous vessels is not sufficient, which is not the most desirable option. These are accessible, adjustable to the required size, free of charge and low risk of infection and thrombosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have